Comments on "Relationship between thromboxane/prostacyclin ratio and diabetic vascular complications".
Sinzinger
H
H
Department of Nuclear Medicine, University of Vienna, Austria. helmut.sinzinger@akh-wien.ac.at
D015121:6-Ketoprostaglandin F1 alpha / Q000031:analogs & derivatives* / Q000652:urine; D000328:Adult; D003924:Diabetes Mellitus, Type 2 / Q000150:complications* / Q000652:urine*; D011464:Epoprostenol / Q000652:urine*; D005260:Female; D006801:Humans; D008297:Male; D015203:Reproducibility of Results; D012107:Research Design / Q000592:standards*; D013929:Thromboxane B2 / Q000031:analogs & derivatives* / Q000652:urine*
D013929:Thromboxane B2; D015121:6-Ketoprostaglandin F1 alpha; C028290:2,3-dinor-6-ketoprostaglandin F1alpha; C049235:11-dehydro-thromboxane B2; D011464:Epoprostenol